Stockscreener 앱 받기
138.78
1.25%
-1.76
시간 외 거래:
138.78
전일 마감가:
$140.54
열려 있는:
$140.1
하루 거래량:
1.60M
Relative Volume:
0.77
시가총액:
$24.01B
수익:
$15.50B
순이익/손실:
$1.33B
주가수익비율:
18.91
EPS:
7.34
순현금흐름:
$2.16B
1주 성능:
+1.09%
1개월 성능:
-7.56%
6개월 성능:
-31.10%
1년 성능:
-38.79%
1일 변동 폭
$138.20
$140.87
1주일 범위
$134.65
$141.95
52주 변동 폭
$134.65
$252.88
아이큐비아 홀딩스 Stock (IQV) Company Profile
명칭
Iqvia Holdings Inc
전화
919-998-2000
주소
2400 ELLIS ROAD, DURHAM, NC
IQV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
138.78 | 23.75B | 15.50B | 1.33B | 2.16B | 7.34 |
|
TMO
Thermo Fisher Scientific Inc
|
402.13 | 150.35B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.01 | 133.69B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
514.33 | 40.28B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
110.88 | 31.05B | 6.53B | 1.26B | 1.31B | 4.35 |
|
MTD
Mettler Toledo International Inc
|
1,157.50 | 23.55B | 3.87B | 863.14M | 864.45M | 40.53 |
아이큐비아 홀딩스 Stock (IQV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-25 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-02-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-12-20 | 개시 | Stephens | Overweight |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-09-04 | 개시 | RBC Capital Mkts | Outperform |
| 2024-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-02-15 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-02-13 | 개시 | BTIG Research | Buy |
| 2023-11-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-03-17 | 개시 | Truist | Buy |
| 2022-12-06 | 개시 | Cowen | Outperform |
| 2022-11-17 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2022-05-24 | 개시 | Guggenheim | Buy |
| 2022-04-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-16 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2020-07-07 | 개시 | Stephens | Equal-Weight |
| 2020-03-02 | 개시 | Deutsche Bank | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-12-13 | 업그레이드 | CFRA | Sell → Hold |
| 2019-11-14 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | 업그레이드 | Mizuho | Neutral → Buy |
| 2019-05-28 | 개시 | SVB Leerink | Outperform |
| 2019-01-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-10-09 | 개시 | UBS | Buy |
| 2018-10-02 | 재확인 | Robert W. Baird | Outperform |
| 2018-07-25 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | 재확인 | Stifel | Buy |
| 2018-07-03 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-03-07 | 업그레이드 | SunTrust | Hold → Buy |
| 2018-01-19 | 개시 | Evercore ISI | Outperform |
모두보기
아이큐비아 홀딩스 주식(IQV)의 최신 뉴스
IQVIA Holdings Inc. Announces First Patient Dosed in Renew Phase 2 Trial of Lti-03 in Patients with Ipf - marketscreener.com
IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV S - GuruFocus
Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF - marketscreener.com
IQVIA’s SWOT analysis: healthcare data giant faces industry headwinds - Investing.com Australia
IQVIA Gears Up to Report Q1 Earnings: What's in Store for the Stock? - MSN
IQVIA (IQV) Projects Global Cancer Drug Spending to Hit $441B by 2029 - GuruFocus
(IQV) Trading Advice - news.stocktradersdaily.com
IQV: Cautious Outlook Amidst Delayed Decisions | IQV Stock News - GuruFocus
IQVIA Holdings Inc (IQV) Stock Price Down 3.4% on May 21 - GuruFocus
IQVIA Stock: Is Wall Street Bullish Or Bearish? - Barchart.com
IQVIA (IQV) Stock Sees Analyst Target Price Adjustment by JP Mor - GuruFocus
IQVIA (IQV) Stock Sees Analyst Target Price Adjustment by JP Morgan | IQV Stock News - GuruFocus
IQV Q1 Earnings Call: Real-World Evidence Drives Outperformance Amid Sector Uncertainty - Yahoo Finance
IQVIA Holdings (NYSE:IQV) Partners With SCRI Innovations To Enhance Global Oncology Trials - Yahoo
IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials - marketscreener.com
IQVIA Teams Up With SCRI to Expedite Development of New Cancer Therapies - marketscreener.com
IQVIA And SCRI Collaborate To Accelerate Global Oncology Trials - marketscreener.com
Is IQVIA Holdings Inc. (IQV) The Most Undervalued Stock With Smart Money Ratings? - Insider Monkey
Deep Dive Into IQVIA Hldgs Stock: Analyst Perspectives (10 Ratings) - Benzinga
IQVIA Holdings (IQV): Analyst Maintains Rating, Lowers Price Tar - GuruFocus
IQVIA Holdings (IQV): Analyst Maintains Rating, Lowers Price Target | IQV Stock News - GuruFocus
Mizuho Adjusts Price Target for Iqvia (IQV) to $190 | IQV Stock News - GuruFocus
Mizuho Adjusts Price Target on IQVIA Holdings to $190 From $210, Maintains Outperform Rating - marketscreener.com
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Questex’s Fierce Biotech Announces 2025 Fierce CRO Award Finalists - GlobeNewswire Inc.
Positive Outlook for IQVIA Holdings Driven by Resilient TAS, Strategic Capital Allocation, and R&D Strength - TipRanks
IQVIA Holdings Inc. (NYSE:IQV) Q1 2025 Earnings Call Transcript - MSN
IQVIA at BofA Securities 2025: Strong Q1 Amid Market Challenges By Investing.com - Investing.com Nigeria
IQVIA at BofA Securities 2025: Strong Q1 Amid Market Challenges - Investing.com
Investing in IQVIA (IQV)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance
(IQV) Investment Analysis and Advice - news.stocktradersdaily.com
IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates - MSN
IQVIA: Q1 Earnings Support Steady Optimism (NYSE:IQV) - Seeking Alpha
IQVIA raises 2025 revenue guidance amid strong TAS growth and expanded AI deployment - MSN
Morgan Stanley Adjusts Price Target on IQVIA Holdings to $185 From $250, Maintains Overweight Rating - marketscreener.com
Truist Financial Sticks to Its Buy Rating for IQVIA Holdings (IQV) - The Globe and Mail
IQVIA Ups Revenue Forecast After Exceeding Profit Estimates - Finimize
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13 - Business Wire
Barclays Lowers IQVIA Holdings (IQV) Price Target to $165 Amid Demand Concerns | IQV stock price - paginasiete.bo
IQVIA (IQV) Target Price Lowered by UBS, Rating Maintained | IQV Stock News - GuruFocus
IQVIA Holdings (IQV): Barclays Lowers Price Target to $165 | IQV Stock News - GuruFocus
Stephens Adjusts Price Target on IQVIA Holdings to $200 From $250, Maintains Overweight Rating - marketscreener.com
Citigroup Adjusts Price Target on IQVIA Holdings to $160 From $210, Maintains Neutral Rating - marketscreener.com
Baird Adjusts Price Target on IQVIA Holdings to $161 From $195, Maintains Neutral Rating - marketscreener.com
Barclays Adjusts Iqvia (IQV) Price Target Amid Demand Concerns | IQV Stock News - GuruFocus
IQVIA reports first-quarter 2025 results - IQVIA
IQVIA Holdings Inc (IQV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
IQVIA Holdings Inc (IQV) Q1 2025 Earnings Call Highlights: Stron - GuruFocus
IQVIA: Q1 Earnings Snapshot - CTPost
Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight - GuruFocus
아이큐비아 홀딩스 (IQV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.46%
2.58%
자본화:
|
볼륨(24시간):